Latest Exploration Partnerships News

Race Oncology has filed pivotal patents on the active (E,E)-bisantrene isomer, potentially extending its drug exclusivity by two decades, while advancing its Phase 1 clinical trial and maintaining a strong cash position.

Swift Networks has locked in key contracts with Australia's largest Aged Care provider and Chevron, while progressing its Swift TV rollout on track for Q3 FY26. The company also completed a $2.2 million capital raise, positioning itself for growth in new markets.

Syrah Resources resumed graphite production at its Balama mine and advanced its Vidalia anode material facility amid supportive US trade tariffs and tax credits, positioning itself strongly in the growing EV battery market.

Global Health Limited has accelerated its MasterCare+ SaaS platform rollout, integrating AI to streamline operations and reduce staff by 10%, while reporting a 25% EBIT improvement despite a delayed R&D refund impacting cash flow.

Race Oncology showcased compelling preclinical data at ESMO 2025 revealing that their drug RC220, combined with doxorubicin, not only shields the heart from toxicity but also boosts anticancer effects, supporting ongoing clinical trials.

Patronus Resources confirms exceptional uranium grades from recent drilling at Thunderball, revealing a new geological model that could unlock over 30km of prospective ground in the Pine Creek Project.

Horizon Gold reports significant gold intercepts from water bore drilling at its Gum Creek Project and launches an AI-powered exploration partnership to accelerate resource growth.

Race Oncology has secured Investigational New Drug approval from South Korea’s regulatory authority, enabling Phase 1 clinical trials of RC220 in combination with doxorubicin for solid tumour patients across four Korean sites.

BPH Global has completed an 18-week R&D collaboration with Singapore Polytechnic, developing two innovative green seaweed kefir beverages that combine health benefits with commercial promise.

Premier1 Lithium has signed a non-binding Letter of Intent with Mineral Mining Services to advance the Wadgingarra project and accelerate exploration at Yalgoo, aiming to de-risk capital and speed up development.

Nutritional Growth Solutions has settled to exit non-core US agreements, unlocking nearly $580,000 in financial relief and streamlining its strategic focus.

AdAlta Limited outlines its innovative 'East to West' cellular immunotherapy approach, in-licensing Asian CAR-T assets and progressing clinical trials in Australia to unlock value. The company also seeks partners for its anti-fibrotic and anti-malarial protein therapeutics.